Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study

被引:36
|
作者
Mindachew, Mesele [1 ]
Deribew, Amare [2 ]
Memiah, Peter [3 ]
Biadgilign, Sibhatu [2 ]
机构
[1] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Gen Publ Hlth, Jimma, Ethiopia
[2] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol, Jimma, Ethiopia
[3] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA
来源
关键词
Isoniazid preventive therapy; People Living with HIV; TB;
D O I
10.11604/pamj.2014.17.26.2641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Isoniazid preventive therapy (IPT) reduces the risk of active TB. IPT is a key public health intervention for the prevention of TB among people living with HIV and has been recommended as part of a comprehensive HIV and AIDS care strategy. However, its implementation has been very slow and has been impeded by several barriers. Objective: The Objective of the study is to assess the perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings in Addis Ababa, Ethiopia in 2010. Methods: A qualitative study using a semi-structured interviewed guide was used for the in-depth interview. A total of 12 key informants including ART Nurse, counselors and coordinators found in four hospitals were included in the interview. Each session of the in-depth interview was recorded via audio tape and detailed notes. The interview was transcribed verbatim. The data was analyzed manually. Results: the findings revealed that poor patient adherence was a major factor; with the following issues cited as the reasons for poor adherence; forgetfulness; lack of understanding of condition and patient non- disclosure of HIV sero-status leading to insubstantial social support; underlying mental health issues resulting in missed or irregular patient appointments; weak patient/healthcare provider relationship due to limited quality interaction; lack of patient information, patient empowerment and proper counseling on IPT; and the deficient reinforcement by health officials and other stakeholders on the significance of IPT medication adherence as a critical for positive health outcomes. Conclusion: Uptake of the implementation of IPT is facing a challenge in resource limited settings. This recalled provision of training/capacity building and awareness creation mechanism for the health workers, facilitating disclosure and social support for the patients is recommended.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study
    Gebrehiwot Teklay
    Tsigemariam Teklu
    Befikadu Legesse
    Kiros Tedla
    Eveline Klinkenberg
    BMC Public Health, 16
  • [2] Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study
    Teklay, Gebrehiwot
    Teklu, Tsigemariam
    Legesse, Befikadu
    Tedla, Kiros
    Klinkenberg, Eveline
    BMC PUBLIC HEALTH, 2016, 16
  • [3] Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions
    Getahun, Haileyesus
    Granich, Reuben
    Sculier, Delphine
    Gunneberg, Christian
    Blanc, Leopold
    Nunn, Paul
    Raviglione, Mario
    AIDS, 2010, 24 : S57 - S65
  • [4] Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study
    Lester, Rebecca
    Hamilton, Robin
    Charalambous, Salome
    Dwadwa, Thobeka
    Chandler, Clare
    Churchyard, Gavin J.
    Grant, Alison D.
    AIDS, 2010, 24 : S45 - S48
  • [5] Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
    Russom, Mulugeta
    Jeannetot, Daniel Y. B.
    Tesfamariam, Sirak
    Stricker, Bruno H.
    Verhamme, Katia
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2022, 15 : 1407 - 1419
  • [6] Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons
    Mary Kagujje
    Muhau L. Mubiana
    Eugenia Mwamba
    Monde Muyoyeta
    BMC Public Health, 19
  • [7] Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons
    Kagujje, Mary
    Mubiana, Muhau L.
    Mwamba, Eugenia
    Muyoyeta, Monde
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [8] Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia
    Lai, J.
    Dememew, Z.
    Jerene, D.
    Abashawl, A.
    Feleke, B.
    Teklu, A. M.
    Ruff, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (03) : 371 - +
  • [9] Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues
    Ait-Khaled, N.
    Alarcon, E.
    Bissell, K.
    Boillot, F.
    Caminero, J. A.
    Chiang, C-Y.
    Clevenbergh, R.
    Dlodlo, R.
    Enarson, D. A.
    Enarson, R.
    Ferroussier, O.
    Fujiwara, P. I.
    Harries, A. D.
    Heldal, E.
    Hinderaker, S. G.
    Kim, S. J.
    Lienhardt, C.
    Rieder, H. L.
    Rusen, I. D.
    Trebucq, A.
    Van Deun, A.
    Wilson, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (08) : 927 - 935
  • [10] Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV
    Date, Anand A.
    Vitoria, Marco
    Granich, Reuben
    Banda, Mazuwa
    Fox, Mayada Youssef
    Gilks, Charlie
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (04) : 253 - 259